142 related articles for article (PubMed ID: 6310058)
1. The spatio-temporal pattern of the axonopathy associated with the neurotoxicity of 3,4-dimethyl-2,5-hexanedione in the rat.
Anthony DC; Giangaspero F; Graham DG
J Neuropathol Exp Neurol; 1983 Sep; 42(5):548-60. PubMed ID: 6310058
[TBL] [Abstract][Full Text] [Related]
2. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings.
Anthony DC; Boekelheide K; Graham DG
Toxicol Appl Pharmacol; 1983 Dec; 71(3):362-71. PubMed ID: 6686353
[TBL] [Abstract][Full Text] [Related]
3. dl- versus meso-3,4-dimethyl-2,5-hexanedione: a morphometric study of the proximo-distal distribution of axonal swellings in the anterior root of the rat.
Rosenberg CK; Genter MB; Szakál-Quin G; Anthony DC; Graham DG
Toxicol Appl Pharmacol; 1987 Feb; 87(2):363-73. PubMed ID: 3824390
[TBL] [Abstract][Full Text] [Related]
4. Evidence that pyrrole formation is a pathogenetic step in gamma-diketone neuropathy.
Genter MB; Szakál-Quin G; Anderson CW; Anthony DC; Graham DG
Toxicol Appl Pharmacol; 1987 Feb; 87(2):351-62. PubMed ID: 3103260
[TBL] [Abstract][Full Text] [Related]
5. Covalent crosslinking of neurofilaments in the pathogenesis of n-hexane neuropathy.
Graham DG; Anthony DC; Szakál-Quin G; Gottfried MR; Boekelheide K
Neurotoxicology; 1985; 6(4):55-63. PubMed ID: 3937075
[TBL] [Abstract][Full Text] [Related]
6. In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy.
Graham DG; Szakál-Quin G; Priest JW; Anthony DC
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4979-82. PubMed ID: 6589640
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of gamma-diketone neurotoxicity: non-neurotoxicity of 3,3-dimethyl-2,5-hexanedione, a gamma-diketone incapable of pyrrole formation.
Sayre LM; Shearson CM; Wongmongkolrit T; Medori R; Gambetti P
Toxicol Appl Pharmacol; 1986 Jun; 84(1):36-44. PubMed ID: 3715867
[TBL] [Abstract][Full Text] [Related]
8. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. II. Dimethyl substitution accelerates pyrrole formation and protein crosslinking.
Anthony DC; Boekelheide K; Anderson CW; Graham DG
Toxicol Appl Pharmacol; 1983 Dec; 71(3):372-82. PubMed ID: 6658787
[TBL] [Abstract][Full Text] [Related]
9. Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport.
Monaco S; Wongmongkolrit T; Shearson CM; Patton A; Schaetzle B; Autilio-Gambetti L; Gambetti P; Sayre LM
Brain Res; 1990 Jun; 519(1-2):73-81. PubMed ID: 2118823
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo studies of the molecular pathogenesis of n-Hexane neuropathy.
Graham DG; Anthony DC; Boekelheide K
Neurobehav Toxicol Teratol; 1982; 4(6):629-34. PubMed ID: 7170020
[TBL] [Abstract][Full Text] [Related]
11. 3,4-Dimethyl-2,5-hexanedione impairs the axonal transport of neurofilament proteins.
Griffin JW; Anthony DC; Fahnestock KE; Hoffman PN; Graham DG
J Neurosci; 1984 Jun; 4(6):1516-26. PubMed ID: 6202854
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration.
Spencer PS; Schaumburg HH
J Neuropathol Exp Neurol; 1977; 36(2):276-99. PubMed ID: 190357
[TBL] [Abstract][Full Text] [Related]
13. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. II. The effects of single doses of neurotoxic and non-neurotoxic diketones and beta, beta'-iminodipropionitrile (IDPN) on the rate and capacity of transport.
Sickles DW
Neurotoxicology; 1989; 10(1):103-11. PubMed ID: 2475834
[TBL] [Abstract][Full Text] [Related]
14. IDPN neuropathy in the cat: coexistence of proximal and distal axonal swellings.
Griffin JW; Gold BG; Cork LC; Price DL; Lowndes HE
Neuropathol Appl Neurobiol; 1982; 8(5):351-64. PubMed ID: 6294544
[TBL] [Abstract][Full Text] [Related]
15. Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy.
Lehning EJ; Dyer KS; Jortner BS; LoPachin RM
Toxicol Appl Pharmacol; 1995 Nov; 135(1):58-66. PubMed ID: 7482540
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.
Spencer PS; Schaumburg HH
J Neuropathol Exp Neurol; 1977; 36(2):300-20. PubMed ID: 190358
[TBL] [Abstract][Full Text] [Related]
17. gamma-diketone peripheral neuropathy. I. Quality morphometric analyses of axonal atrophy and swelling.
Lehning EJ; Jortner BS; Fox JH; Arezzo JC; Kitano T; LoPachin RM
Toxicol Appl Pharmacol; 2000 Jun; 165(2):127-40. PubMed ID: 10828208
[TBL] [Abstract][Full Text] [Related]
18. Cytoskeletal disorganization induced by local application of beta, beta'-iminodipropionitrile and 2,5-hexanedione.
Griffin JW; Fahnestock KE; Price DL; Cork LC
Ann Neurol; 1983 Jul; 14(1):55-61. PubMed ID: 6684411
[TBL] [Abstract][Full Text] [Related]
19. Evolution of axonal swellings in cats intoxicated with beta,beta'-iminodipropionitrile (IDPN). An electrophysiological and morphological study.
Delio DA; Fiori MG; Sharer LR; Lowndes HE
Exp Neurol; 1985 Feb; 87(2):235-48. PubMed ID: 2981699
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of proximal neurofilamentous giant axonal swellings: implications for the pathogenesis of amyotrophic lateral sclerosis.
Gold BG
Toxicology; 1987 Oct; 46(2):125-39. PubMed ID: 3313811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
